|
|
Volumn 13, Issue 7, 2016, Pages 395-
|
|
Immunotherapy: Study deciphers enigmatic mechanism of PD-L1 overexpression
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PD L1 PROTEIN;
PROTEIN ANTIBODY;
TUMOR MARKER;
UNCLASSIFIED DRUG;
PROGRAMMED DEATH 1 LIGAND 1;
3' UNTRANSLATED REGION;
CANCER IMMUNOTHERAPY;
GENE MAPPING;
GENE OVEREXPRESSION;
GENETIC VARIABILITY;
HODGKIN DISEASE;
HUMAN;
IMMUNOHISTOCHEMISTRY;
IMMUNOSUPPRESSIVE TREATMENT;
LARGE CELL LYMPHOMA;
MARKER GENE;
NOTE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
T CELL LEUKEMIA;
IMMUNOTHERAPY;
B7-H1 ANTIGEN;
HUMANS;
IMMUNOTHERAPY;
|
|
EID: 84975509431
PISSN: 17594774
EISSN: 17594782
Source Type: Journal
DOI: 10.1038/nrclinonc.2016.97 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
